IL-13-PE has also been shown to work synergistically with paclitaxel in an immunodeficient animal model of HNSCC [29] with gemcitabine for pancreatic cancer [30] and a DNA vaccine of IL-13Rα2 in melanoma, breast, and sarcoma tumor models [20]. This evidence concerns the gene IL13RA2 and pancreatic neoplasm.